p38 MAPK-IN-1 is primarily used in research to study the role of p38 MAPK signaling pathways in various cellular processes. It is a selective inhibitor of p38 MAPK, making it valuable for investigating inflammation, stress responses, and apoptosis in experimental models. Researchers utilize this compound to explore its potential therapeutic effects in diseases such as cancer, autoimmune disorders, and neurodegenerative conditions. By inhibiting p38 MAPK activity, it helps elucidate the pathway's involvement in disease mechanisms, aiding in the development of targeted treatments. Additionally, it is employed in preclinical studies to assess its efficacy and safety in modulating specific biological responses.